Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hinge Health (HNGE) Change in Receivables (2024 - 2025)

Hinge Health (HNGE) has disclosed Change in Receivables for 2 consecutive years, with -$21.0 million as the latest value for Q4 2025.

  • Quarterly Change in Receivables fell 32.07% to -$21.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$54.9 million through Dec 2025, changed N/A year-over-year, with the annual reading at $26.6 million for FY2025, 1887.09% up from the prior year.
  • Change in Receivables hit -$21.0 million in Q4 2025 for Hinge Health, down from -$12.0 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of -$6.1 million in Q3 2024 to a low of -$21.0 million in Q4 2025.